Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-06

Clinical Trial Update: Effect of CPP-ACP With/Without Fl on White Spot Lesion,Salivary pH and fl Release in High Caries Risk Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating CPP-ACP with and without fluoride on white spot lesions, salivary pH, and fluoride release in high caries risk patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CPP-ACP (Casein phosphopeptide-amorphous calcium phosphate)
  • Fluoride (sodium fluoride)

Snippet

Sponsor: Cairo University | Conditions: Caries | Phase 3 | Status: UNKNOWN